Janet B. McGill
Washington University in St. Louis
212 Papers
924 Citations
Janet B. McGill is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Diabetes mellitus & Medicine. The author has an hindex of 61, co-authored 182 publications.
Chat about Author
Papers
Addition of exenatide twice daily to basal insulin for the treatment of type 2 diabetes: clinical studies and practical approaches to therapy
TL;DR: This data indicates that the final stage of intensification may require prandial insulin, adding complexity and increased risks of hypoglycaemia and weight gain.
17
Making Insulin Accessible: Does Inhaled Insulin Fill an Unmet Need?
TL;DR: Findings imply that TI may be useful in helping to overcome patient resistance to insulin, improve adherence and mitigate clinical inertia in health-care providers, with potential beneficial effects on glycemic control.
17
Effect of a Shoulder Movement Intervention on Joint Mobility, Pain, and Disability in People With Diabetes: A Randomized Controlled Trial.
Michael J. Mueller,Christopher J. Sorensen,Janet B. McGill,B. Ruth Clark,Catherine E. Lang,Ling Chen,Kathryn L. Bohnert,Mary K. Hastings +7 more
TL;DR: A progressive shoulder movement program can have meaningful effects on active motion and symptoms in people with type 2 diabetes and mild-to-moderate shoulder symptoms, with symptom improvement lasting at least 9 months.
The relationship between eating patterns and metabolic control in patients with non-insulin-dependent diabetes mellitus (NIDDM).
TL;DR: Maintaining consistent eating patterns should be further evaluated as an important component of dietary instruction for patients with NIDDM.
16
Comparing the effects of insulin glargine and thiazolidinediones on plasma lipids in type 2 diabetes: a patient‐level pooled analysis
Ajay Chaudhuri,Julio Rosenstock,Andres DiGenio,Luigi F. Meneghini,Priscilla Hollander,Janet B. McGill,Paresh Dandona,John Ilgenfritz,Matthew C. Riddle +8 more
TL;DR: The prevalence of dyslipidaemia and the risk of cardiovascular disease are elevated in patients with type 2 diabetes and this analysis compared the effects of insulin glargine versus thiazolidinediones (TZDs) on lipid profiles.
16